Eric Devroe Acrivon Therapeutics, Inc. (ACRV) insider trading activity

Shares Held (Direct Ownership) 66.5K

0.91% 3M change

3.71% 12M change

Total Value Held N/A

Eric Devroe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 14 2025	SELL Payment of exercise price or tax liability	$698 $1.14 p/Share	613 Reduced 0.91%	66,534 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$3,924 $5.42 p/Share	724 Reduced 1.07%	67,147 Common Stock
Nov 14 2024	SELL Payment of exercise price or tax liability	$4,854 $7.92 p/Share	613 Reduced 0.9%	67,871 Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$4,303 $7.02 p/Share	613 Reduced 0.89%	68,484 Common Stock
May 17 2024	BUY Exercise of conversion of derivative security	$10,400 $1.04 p/Share	10,000 Added 12.64%	69,097 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$5,124 $8.36 p/Share	613 Reduced 1.03%	59,097 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$2,458 $3.4 p/Share	723 Reduced 1.2%	59,710 Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$12,446 $5.08 p/Share	2,450 Reduced 3.9%	60,433 Common Stock
Jun 05 2023	BUY Exercise of conversion of derivative security	$9,594 $1.04 p/Share	9,225 Added 12.79%	62,883 Common Stock
Nov 14 2022	BUY Grant, award, or other acquisition	-	33,383 Added 38.35%	53,658 Common Stock

Chief Operating Officer

Watertown, MA

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

Receive news related to Acrivon Therapeutics, Inc.